Plasma Transfusion


Johns Hopkins Investigator & Collaborators Receive $4m for COVID-19 Plasma Transfusion Clinical Trial

Thanks to a U.S. Food and Drug Administration green light, and some financial support from Bloomberg Philanthropies and the State of Maryland, Johns Hopkins University researchers will proceed to test a therapy for COVID-19 that uses plasma from recovering patients....

‘Unprecedented Times call for Bold Moves’ as Competitive Plasma Firms Unite to Battle COVID-19

CSL Behring and Takeda Pharmaceutical Company have initiated an alliance bringing together the world’s leading plasma companies to focus on developing and delivering hyperimmune immunoglobulin to help fight the global war on COVID-19. Led by Australian and American...

Pin It on Pinterest